StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)

Close on Nov 17, 2026Market cap $148.68MP/E –Yield –

Abeona Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Abeona Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$76.44M. For fiscal 2025 it was -$76.33M. The highest annual figure on record is $1.00K in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$76.33M–
FY2024Dec 31, 2024-$56.02M–
FY2023Dec 31, 2023-$37.01M–
FY2022Dec 31, 2022-$43.48M–
FY2021Dec 31, 2021-$65.67M–
FY2020Dec 31, 2020-$35.02M–
FY2019Dec 31, 2019-$62.82M–
FY2018Dec 31, 2018-$39.11M–
FY2017Dec 31, 2017-$22.66M–
FY2016Dec 31, 2016-$13.01M–
FY2015Dec 31, 2015-$10.42M–
FY2014Dec 31, 2014-$1.61M-161200.0%
FY2013Dec 31, 2013$1.00K–
FY2012Dec 31, 2012-$3.96M–
FY2011Dec 31, 2011-$7.61M–
FY2010Dec 31, 2010-$6.86M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$17.50M–
Q1 FY2026Mar 31, 2026-$19.80M–
Q4 FY2025Dec 31, 2025-$17.95M–
Q3 FY2025Sep 30, 2025-$21.19M–
Q2 FY2025Jun 30, 2025-$18.78M–
Q1 FY2025Mar 31, 2025-$18.40M–
Q4 FY2024Dec 31, 2024-$16.56M–
Q3 FY2024Sep 30, 2024-$12.23M–
Q2 FY2024Jun 30, 2024-$12.68M–
Q1 FY2024Mar 31, 2024-$14.54M–
Q4 FY2023Dec 31, 2023-$9.24M–
Q3 FY2023Sep 30, 2023-$5.75M–
Q2 FY2023Jun 30, 2023-$10.28M–
Q1 FY2023Mar 31, 2023-$11.74M–
Q4 FY2022Dec 31, 2022-$13.99M–
Q3 FY2022Sep 30, 2022-$6.79M–
Q2 FY2022Jun 30, 2022-$9.01M–
Q1 FY2022Mar 31, 2022-$13.69M–
Q4 FY2021Dec 31, 2021-$30.26M–
Q3 FY2021Sep 30, 2021-$10.33M–
Q2 FY2021Jun 30, 2021-$11.49M–
Q1 FY2021Mar 31, 2021-$13.59M–
Q4 FY2020Dec 31, 2020-$1.61M–
Q3 FY2020Sep 30, 2020-$10.70M–
Q2 FY2020Jun 30, 2020-$9.48M–
Q1 FY2020Mar 31, 2020-$13.23M–
Q4 FY2019Dec 31, 2019-$14.25M–
Q3 FY2019Sep 30, 2019-$18.25M–
Q2 FY2019Jun 30, 2019-$15.24M–
Q1 FY2019Mar 31, 2019-$15.08M–
Q4 FY2018Dec 31, 2018-$16.97M–
Q3 FY2018Sep 30, 2018-$9.04M–
Q2 FY2018Jun 30, 2018-$9.02M–
Q1 FY2018Mar 31, 2018-$4.08M–
Q4 FY2017Dec 31, 2017-$5.05M–
Q3 FY2017Sep 30, 2017-$6.77M–
Q2 FY2017Jun 30, 2017-$4.98M–
Q1 FY2017Mar 31, 2017-$5.86M–
Q4 FY2016Dec 31, 2016-$3.39M–
Q3 FY2016Sep 30, 2016-$3.99M–

More Abeona Therapeutics figures

See a number that looks wrong?